Private Advisor Group LLC Decreases Stake in Masimo Co. (MASI)

Private Advisor Group LLC lessened its stake in Masimo Co. (NASDAQ:MASI) by 9.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 10,158 shares of the medical equipment provider’s stock after selling 1,002 shares during the quarter. Private Advisor Group LLC’s holdings in Masimo were worth $891,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the stock. USA Mutuals Advisors Inc. acquired a new stake in shares of Masimo in the fourth quarter valued at approximately $110,000. Swiss National Bank increased its holdings in shares of Masimo by 3.4% in the fourth quarter. Swiss National Bank now owns 84,100 shares of the medical equipment provider’s stock valued at $7,132,000 after purchasing an additional 2,800 shares during the last quarter. Renaissance Group LLC acquired a new stake in shares of Masimo in the fourth quarter valued at approximately $369,000. California Public Employees Retirement System increased its holdings in shares of Masimo by 11.4% in the fourth quarter. California Public Employees Retirement System now owns 109,494 shares of the medical equipment provider’s stock valued at $9,285,000 after purchasing an additional 11,178 shares during the last quarter. Finally, Teacher Retirement System of Texas increased its holdings in shares of Masimo by 319.7% in the fourth quarter. Teacher Retirement System of Texas now owns 16,826 shares of the medical equipment provider’s stock valued at $1,427,000 after purchasing an additional 12,817 shares during the last quarter. 82.18% of the stock is owned by hedge funds and other institutional investors.

Shares of Masimo Co. (NASDAQ:MASI) opened at $85.58 on Wednesday. The stock has a market capitalization of $4,478.85, a price-to-earnings ratio of 13.54, a price-to-earnings-growth ratio of 3.29 and a beta of 0.85. Masimo Co. has a one year low of $80.69 and a one year high of $104.71.

Several research firms recently commented on MASI. Zacks Investment Research cut Masimo from a “buy” rating to a “hold” rating in a report on Wednesday, February 7th. BidaskClub cut Masimo from a “hold” rating to a “sell” rating in a report on Thursday, December 7th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and issued a $108.00 price target on shares of Masimo in a report on Friday, November 3rd. One analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $104.60.

In other Masimo news, EVP Yongsam Lee sold 5,900 shares of the firm’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $88.31, for a total transaction of $521,029.00. Following the completion of the sale, the executive vice president now owns 70,800 shares of the company’s stock, valued at $6,252,348. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Sanford Fitch sold 2,000 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $93.07, for a total value of $186,140.00. Following the sale, the director now directly owns 68,249 shares of the company’s stock, valued at approximately $6,351,934.43. The disclosure for this sale can be found here. In the last three months, insiders have sold 48,098 shares of company stock valued at $4,315,261. 13.10% of the stock is owned by insiders.

ILLEGAL ACTIVITY WARNING: This story was reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://stocknewstimes.com/2018/02/21/private-advisor-group-llc-decreases-stake-in-masimo-co-masi.html.

About Masimo

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply